Optiscan Imaging (OIL) Stock Overview
Engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
OIL Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Optiscan Imaging Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.11 |
| 52 Week High | AU$0.26 |
| 52 Week Low | AU$0.10 |
| Beta | 0.71 |
| 1 Month Change | -26.67% |
| 3 Month Change | -21.43% |
| 1 Year Change | -55.10% |
| 3 Year Change | 0% |
| 5 Year Change | 175.00% |
| Change since IPO | -45.00% |
Recent News & Updates
Recent updates
Here's Why We're Not Too Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Situation
Sep 27
We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Jan 16We're Keeping An Eye On Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Sep 19We're Not Very Worried About Optiscan Imaging's (ASX:OIL) Cash Burn Rate
Jun 10Optiscan Imaging (ASX:OIL) Is In A Strong Position To Grow Its Business
Dec 30We're Not Worried About Optiscan Imaging's (ASX:OIL) Cash Burn
Aug 02How Much Of Optiscan Imaging Limited (ASX:OIL) Do Insiders Own?
Mar 04Can You Imagine How Jubilant Optiscan Imaging's (ASX:OIL) Shareholders Feel About Its 253% Share Price Gain?
Dec 02Shareholder Returns
| OIL | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | -8.3% | 0.3% | 0.1% |
| 1Y | -55.1% | -10.2% | 8.3% |
Return vs Industry: OIL underperformed the Australian Medical Equipment industry which returned -10.2% over the past year.
Return vs Market: OIL underperformed the Australian Market which returned 8.3% over the past year.
Price Volatility
| OIL volatility | |
|---|---|
| OIL Average Weekly Movement | 16.5% |
| Medical Equipment Industry Average Movement | 10.8% |
| Market Average Movement | 9.4% |
| 10% most volatile stocks in AU Market | 17.8% |
| 10% least volatile stocks in AU Market | 3.8% |
Stable Share Price: OIL's share price has been volatile over the past 3 months compared to the Australian market.
Volatility Over Time: OIL's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Camile Farah | www.optiscan.com |
Optiscan Imaging Limited engages in the development, manufacture, and commercialization of endomicroscopic digital imaging technology solutions for medical, translational, and pre-clinical applications in Australia, Germany, China, and the United States. It offers InVivage, an intra-oral endomicroscope for oral cancer imaging; InVue, a microscopic medical imaging device for precision surgery; and ViewnVivo, an endomicroscope for life sciences, pre-clinical and translational research. The company has a collaboration agreement with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system for applications in robotic surgery.
Optiscan Imaging Limited Fundamentals Summary
| OIL fundamental statistics | |
|---|---|
| Market cap | AU$91.89m |
| Earnings (TTM) | -AU$4.98m |
| Revenue (TTM) | AU$4.96m |
Is OIL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OIL income statement (TTM) | |
|---|---|
| Revenue | AU$4.96m |
| Cost of Revenue | AU$667.31k |
| Gross Profit | AU$4.29m |
| Other Expenses | AU$9.27m |
| Earnings | -AU$4.98m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.006 |
| Gross Margin | 86.55% |
| Net Profit Margin | -100.32% |
| Debt/Equity Ratio | 1.1% |
How did OIL perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/30 22:59 |
| End of Day Share Price | 2025/06/30 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Optiscan Imaging Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.